MyoScience raises $10.4M for aesthetic medicine
MyoScience, a stealth-mode medical company based in Redwood City, Calif., has taken $10.4 million in a second funding for continuing clinical trials.
The company has not yet disclosed exactly what use its aesthetic devices will have, although CEO Lisa Elkins hinted that aging eyes and skin might be the target to VentureWire, which first reported the funding.
The funding was led by Nexus Medical Partners, with participation from Accuitive Medical Ventures, De Novo Ventures and Saratoga Ventures. The round is still open.
Next Story: Nanotech chip timing co. Sand 9 raises $8M
Previous Story: Social game creator SGN gets funding from Amazon’s Bezos, who looks for more Web hits
About the Author, Chris Morrison
Chris Morrison writes about cleantech and environmental issues for VentureBeat, with occasional forays into gaming and semantic technology. He got his start writing about tech for Business 2.0 magazine, but quickly realized new media was the ticket when that institution closed its doors in 2007. Chris has also covered public equities and regulatory issues. He originally hails from southern Virginia, graduated from Evergreen State College in Washington, and now lives in San Francisco.